跳至主要内容
临床试验/NCT04850937
NCT04850937已完成不适用

Effect of Low-dose Esketamine on Postoperative Depression in Patients With Breast Cancer

Yangzhou University1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2021年2月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
90
试验地点
1
主要终点
depression score

研究概览

简要总结

esketamine is an optical isomer of ketamine. Compared with ketamine, esketamine has the characteristics of higher effective value, stronger receptor affinity, less adverse reactions of nervous system, and pharmacokinetics is controllable.

Domestic and foreign studies have focused on the therapeutic effect of esketamine on major depression, but less attention has been paid to perioperative depression.This study intends to explore the effect of small doses of esketamine on patients with breast cancer.Postoperative depression and pain are observed.

详细描述

This study intends to explore the effect of small doses of esketamine on patients with breast cancer.WE pay attention to :

  1. Safety of low-dose single intravenous injection of esketamine (1)The influence of intraoperative vital signs of patients after medication, such as blood pressure and heart rate fluctuation; (2)the duration of recovery after anesthesia; (3)postoperative adverse reactions, such as nausea and vomiting, dizziness and diplopia, respiratory depression, laryngeal spasm, delirium agitation, etc
  2. Effect of single intravenous injection of low-dose ketamine on postoperative depression in patients undergoing radical mastectomy (1) 1 day before surgery, 2 days, 5 days, 30 days, 90 days after surgery Hamilton Depression Scale scores; (2) The serum leptin level 1 day before surgery, 2 days after surgery and 5 days after surgery; (3) Correlation between depression scale score and leptin level
  3. Effects of low dose esketamine on acute and chronic pain in patients undergoing radical mastectomy
  • visual analogue scale scores at 6, 12 and 24 hours after surgery;

  • visual analogue scale scores at 3, 5, 30 and 90 days after surgery;

  • the number of analgesic remedies

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

盲法说明

esketamine 10ml (5mg/ml) and normal saline 10ml were respectively set as drug A or drug B.

Without the knowledge of the experimenter, the predetermined dose of drug A or B will be given to the experimenter before induction of anesthesia, with 0.05 mL /kg for each patient.

After all samples are collected, the third party will announce the grouping and medication.

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • (1) Female patients who planned to undergo unilateral modified radical mastectomy in breast surgery; (2)Years of education ≥5 years,American Society of Anesthesiologists Ⅰ-II grade; (3) All patients undergoing surgery within 1 week after diagnosis of breast cancer, and do not receive preoperative radiotherapy or chemotherapy; (4) All the patients were married and had children, and were mainly cared for by their immediate family members after surgery.

排除标准

  • (1) Antidepressant treatment was received within the last 2 months; (2) previous personality disorder, intellectual retardation, brain injury or brain disease, combined with schizophrenia, mania and other mental diseases; (3) Preoperative patients with hyperthyroidism or hypothyroidism, severe cardiovascular disease, diabetes, severe blood deficiency, and abnormal heart, lung, liver, and kidney functions; (4) with diseases of the immune system, or use drugs that have obvious effects on the immune system; (5) Pregnancy or lactation;

研究组 & 干预措施

Group S

Experimental

The experimental group will be given 0.25mg/kg esketamine slowly intravenously after anesthesia induction During administration, blood pressure and heart rate were observed.

干预措施: Esketamine (Drug)

Group C

Placebo Comparator

The control group will receive the same amount of normal saline after anesthesia induction

干预措施: normal saline (Drug)

结局指标

主要结局

depression score

时间窗: Change from Baseline score at 3 months

The total rough score is the sum of all the scores in the 20 items, and then the rough score is multiplied by 1.25 to take the round part to get the standard score. An SDS score of 53 to 62 is classified as mild depression, 63 to 72 as moderate depression, and 73 or more as major depression.

次要结局

  • The serum leptin level(Change from 1 day before surgery to 90 days after surgery)
  • pain score(Change from Baseline score at 3 months)

研究者

发起方
Yangzhou University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ma Hong

Department of Anesthesiology, Yangzhou University Affiliated Hospital

Yangzhou University

研究点 (1)

Loading locations...

相似试验